Domů › Rakovina (všechny typy) › Kalifornie › San Francisco
Klinické studie Rakovina (všechny typy) v San Francisco, CA
35 studií pro Rakovina (všechny typy) hledá účastníky v lokalitách v San Francisco a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
PediRISE Feasibility
Probíhá nábor
- University of California San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Probíhá nábor
- Kaiser Permanente-San Francisco, San Francisco
Intratumoral N17350 in Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of California, San Francisco, San Francisco
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Probíhá náborFáze 2
- Kaiser Permanente - South San Francisco Medical Center, San Francisco
- California Pacific Medical Center Research Institute, San Francisco
- Kaiser Permanente - San Francisco Medical Center, San Francisco
- a dalších 1
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Probíhá náborFáze 2/3
- University of California, San Francisco- California, San Francisco
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Probíhá náborObservační studie
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
Probíhá náborObservační studie
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Probíhá náborFáze 1
- UCSF, San Francisco
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Probíhá náborFáze 1
- UCSF, San Francisco
Project: Every Child for Younger Patients With Cancer
Probíhá náborObservační studie
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
International Rare Brain Tumor Registry
Probíhá náborObservační studie
- University of California San Francisco, San Francisco
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Probíhá náborFáze 3
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
Probíhá nábor
- Stanford Cancer Institute, San Francisco
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Probíhá náborFáze 2
- The Unviersity of California, San Francisco (UCSF), San Francisco
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Probíhá náborFáze 2
- 014, San Francisco
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Probíhá náborFáze 1
- University of California San Francisco, San Francisco
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- UCSF Medical Center at Mission Bay, San Francisco
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Probíhá náborFáze 1/2
- UCSF Medical Center - Mission Bay, San Francisco
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Childhood Cancer Survivor Study
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- University of California-San Francisco, San Francisco
Multisite Implementation of COMPRENDO
Probíhá náborVítáni zdraví dobrovolníci
- University of California San Francisco Benioff Children's Hospitals, San Francisco
Galleri® in the Medicare Population.
Probíhá náborVítáni zdraví dobrovolníci
- University of California San Francisco Health System, San Francisco
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Probíhá náborFáze 2
- University of California San Francisco (UCSF), San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Probíhá nábor
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Probíhá náborFáze 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
Probíhá nábor
- University of California, San Francisco, San Francisco
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Probíhá náborFáze 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Primary Tumor Research and Outcomes Network
Probíhá náborObservační studie
- UCSF Medical Center, San Francisco
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Probíhá náborObservační studie
- University of California San Francisco, San Francisco
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Probíhá náborFáze 2
- University of California, San Francisco, San Francisco
ChangeGradients: Promoting Adolescent Health Behavior Change
Probíhá náborVítáni zdraví dobrovolníci
- University of California San Francisco Adolescent and Young Adult Medicine Clinic, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, San Francisco
A Study of NX-1607 in Adults With Advanced Malignancies
Probíhá náborFáze 1
- University of California, San Francisco, San Francisco
Studie Rakovina (všechny typy) v jiných městech
- Houston, TX121 studií
- New York City, NY109 studií
- Boston, MA85 studií
- Los Angeles, CA74 studií
- Nashville, TN65 studií
- Philadelphia, PA59 studií
- Washington, DC58 studií
- Durham, NC58 studií
- Chicago, IL51 studií
- Atlanta, GA49 studií
- Seattle, WA49 studií
- Arlington, VA48 studií
Další studie v San Francisco
- Rakovina prostaty45 studií
- Rakovina prsu43 studií
- Nemalobuněčný plicní karcinom36 studií
- Srdeční selhání29 studií
- Metastatický karcinom28 studií
- Rakovina plic22 studií
- Melanom22 studií
- Rakovina slinivky břišní20 studií
- Rakovina vaječníků19 studií
- Kolorektální karcinom18 studií
- Kardiovaskulární onemocnění18 studií
- Glioblastom17 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.